You will find all the answers to the most frequently asked questions below:
If you have private insurance, we invite you to contact your insurer and provide the DIN ;
If you will be using the RAMQ, you can verify on the RAMQ website or ask your local pharmacist.
We invite you to verify with your Oncology Drug Access Coordinators or your doctor
We invite you to contact your insurance company to find out why, and then contact your Oncology Drug Access Coordinators
You must register with the RAMQ, then consult with your Oncology Drug Access Coordinator in order to send the authorization request to the RAMQ.
Brand-name or innovator drugs are products patented by pharmaceutical companies. Generic drugs are copies of them and are cheaper. They contain the same medicinal ingredients and are approved by Health Canada, and abide by the same quality standards.
A biosimilar is a drug that is similar to the original with clinical effects equivalent to the original.
Private insurance and/or RAMQ.
8. What is the difference in cancer drug coverage (private and public) if I have oral and/or intravenous treatment?
First, you need to verify if the authorization has expired
Your pharmacist can request a temporary extension from the RAMQ, while your doctor can make a request to the RAMQ for an authorization to pursue treatment.
You should call the RAMQ first. Usually, there is a number on the letter you can use to contact them, should you need more information.
You can also contact your Oncology Drug Access Coordinators or your treating physician. They can provide additional information and to do the necessary follow-ups with you.